---
title: "Schizophrenia - APA Practice Guidelines 2020"
organization: "APA"
year: 2020
version: "3.0"
citation_key: "APA_SCZ_2020"
url: "https://www.psychiatry.org"
---

# Schizophrenia Treatment Guidelines

## First Episode Psychosis

### Antipsychotic Selection
**Preferred:**
- Aripiprazole
- Risperidone
- Olanzapine
- Quetiapine

**Consider avoiding:**
- Haloperidol (except emergencies)
- Clozapine (reserve for treatment resistance)

### Dosing Principles
- Start low, go slow
- Use minimum effective dose
- Reassess after 2-4 weeks

## Treatment-Resistant Schizophrenia

**Definition:**
- Failed 2+ adequate trials of different antipsychotics
- Each trial: adequate dose Ã— 4-6 weeks

**Treatment:**
- Clozapine is gold standard
- Requires monitoring: ANC, metabolic parameters

## Long-acting Injectables (LAI)
**Consider for:**
- Non-adherence history
- Patient preference
- Relapse prevention

**Options:**
- Paliperidone palmitate
- Aripiprazole monohydrate
- Risperidone microspheres

## Monitoring Requirements
- Metabolic: Weight, glucose, lipids (baseline, 3 mo, annually)
- EPS: AIMS quarterly
- Prolactin: If symptomatic
